Aphios Corporation
Explore Aphios’ hybrid model of drug development and licensing powered by 87 patents and $50M in funding.
- Est. revenue
- $2.5M–$5M
- Total raised
- $2.5M
- Latest round
- Grant
- Employees
- 14
Funding & revenue at Aphios Corporation
How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.
Estimated annual revenue
$2.5M–$5M
Modeled range, not company-reported
Total capital raised
$2.5M
4 known investors
Latest round
Grant · $65K
Oct 2025
Publicly traded
APHIOSCORPORATION
Investors
Growth signals
How fast Aphios Corporation is adding people, roles, and audience.
Employees
14
Reported band 11-50
LinkedIn followers
1K
+10.7% year over year
Headcount change
- MoM
- 0%
- QoQ
- 0%
- 6mo
- 0%
- YoY
- +7.7%
- 2yr
- +7.7%
0 people
0 people
0 people
+1 people
+1 people
Team composition
Where Aphios Corporation concentrates its people — a read on which function a fractional leader would plug into.
By function
- Accounting214%
- Consulting214%
- Operations214%
- Legal17%
- Sales17%
- Research17%
- Real Estate17%
- Business Development17%
By region
- United States13
- Greater Boston12
- Massachusetts, United States11
- Woburn, MA2
- Arlington, MA2
- Framingham, MA2
Inside Aphios Corporation
What the business focuses on, where it operates, and how employees rate it.
Specialties
Categories
Markets
Aphios Corporation in the news
Recent coverage picked up alongside the firmographic refresh.
- Aphios Corporation Announces Notice of Allowance for Nove...
May 2026
- Aphios Corporation Announces Notice of Allowance for Novel Bryoid Composition Patent Targeting Alzheimer’s Disease, Multiple Sclerosis, HIV Latency and Cancer
May 2026
- Aphios Corporation Announces Notice of Allowance for Novel Bryoid Composition Patent Targeting Alzheimer’s Disease, Multiple Sclerosis, HIV Latency and Cancer
May 2026
- Aphios Corporation Awarded NIH Grant to Advance Botanical Drug Zindol® for Cancer Treatment Related Nausea and Vomiting
Oct 2025
- Aphios Corporation Awarded NIH Grant to Advance Botanical Drug Zindol® for Cancer Treatment Related Nausea and Vomiting
Oct 2025
- Aphios Receives U.S. Patent Allowance for Groundbreaking Room Temperature-Stable, Single-Shot mRNA COVID-19 Vaccine
May 2025
Jobs
0No open roles right now — view past roles below
Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed September 2, 2026.
About this page
This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Aphios Corporation, you can claim this page to manage and enhance it.